News
For this Wellness Wednesday, we spoke with Cruz about Cryo T-shock Therapy. “We’re going to localize the heat first, along ...
About IceCure Medical IceCure Medical (Nasdaq: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy systems for the destruction of tumors (benign and cancerous ...
The 124 Patients who received only endocrine therapy with cryoablation had a 5-year IBTR rate of 3.22% (4 recurrences out of 124 patients). Expanding the Use of Cryoablation on T1 Breast Cancers ...
About IceCure Medical IceCure Medical (Nasdaq: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy systems for the destruction of tumors (benign and cancerous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results